Showing results (131-140 of 185) with videos related to

Sort By:
Pageof 19
Oncogenesis|April 21, 2022
Salt-Inducible Kinase 1 is a potential therapeutic target in Desmoplastic Small Round Cell TumorAlifiani Bonita Hartono, Hong-Jun Kang, Lawrence Shi, et al.
Non-Coding RNA|April 17, 2018
Argonaute 2 Expression Correlates with a Luminal B Breast Cancer Subtype and Induces Estrogen Receptor Alpha Isoform VariationAdrienne K Conger, Elizabeth C Martin, Thomas J Yan, et al.
Frontiers in Bioscience (Landmark Edition)|August 6, 2025
Adipose Stromal Cell Heterogeneity and Trafficking: Implications for Breast Cancer Metastasis and ObesityCaroline R McCauley, Tamara R Fischer, Nicole M Cullen, et al.
Chemical & Biomedical Imaging|March 27, 2026
Integrative Raman Spectroscopy and Multi-Omics Analysis of Lipid and Matrix Protein Heterogeneity in Triple-Negative Breast CancerElnaz Sheikh, Khudeja Salim, Praveen Kumar Guttula, et al.
Frontiers in Pharmacology|August 1, 2026
Pharmacologic targeting of midasin (MDN1) reveals a potential therapeutic vulnerability in ESR1-mutant breast cancerMounika Pamukuntla, Afia Ohemeng, Bipika Banjara, et al.
Endocrinology|September 24, 2010
Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640James W Antoon, Martin D White, William D Meacham, et al.
Pharmacological Research|April 6, 2023
LKB1 signaling and patient survival outcomes in hepatocellular carcinomaKhoa Nguyen, Katherine Hebert, Emily McConnell, et al.
Breast Cancer Research : BCR|May 24, 2019
Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft modelsRachel A Sabol, Annie C Bowles, Alex Côté, et al.
Scientific Reports|July 31, 2012
Altered death receptor signaling promotes epithelial-to-mesenchymal transition and acquired chemoresistanceJames W Antoon, Rongye Lai, Amanda P Struckhoff, et al.
Molecular Carcinogenesis|August 23, 2012
Preferential star strand biogenesis of pre-miR-24-2 targets PKC-alpha and suppresses cell survival in MCF-7 breast cancer cellsElizabeth C Martin, Steven Elliott, Lyndsay V Rhodes, et al.
Pageof 19